SCHEMBL795497

SCHEMBL795497

CC=CCCC=CC(N)Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.48
SLC6A2 P23975 2/20 0.46
TAAR1 Q96RJ0 2/20 0.46
MAOA P21397 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
CYP2A6 P11509 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
ANPEP P15144 1/20 0.43
CYP2D6 P10635 1/20 0.43
ALPI P09923 1/20 0.38
PKM P14618 1/20 0.38
PTGS1 P23219 1/20 0.38
XIAP P98170 1/20 0.38
SLC7A5 Q01650 1/20 0.38
SCN4A P35499 2/20 0.37
SLC15A1 P46059 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL795495 1.00 EPHX1 (0.48) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL11828128 0.80 SLC6A2 (0.50) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL11828122 0.80 SLC6A2 (0.50) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL902546 0.79 EPHX1 (0.61) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL902538 0.79 EPHX1 (0.61) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL2736329 0.79 EPHX1 (0.61) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL7307677 0.79 EPHX1 (0.61) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL795585 0.79 DPP4 (0.37) TAAR1
SCHEMBL795583 0.79 DPP4 (0.37) TAAR1
SCHEMBL12491357 0.78 MAOB (0.54) EPHX1SLC6A2TAAR1MAOASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616056-A1 TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS Neuroquest Inc. (CA) 2013-07-24 EP disclosed
WO-2012034232-A1 TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS NEUROQUEST INC. (CA) 2012-03-22 WO disclosed